Hormone-treated primary operable breast carcinoma; a pathological study of 33 cases.

Abstract

CancerVolume 4, Issue 1 p. 136-140 ArticleFree Access Hormone-treated primary operable breast carcinoma. A pathological study of thirty-three cases John T. Godwin M.D., John T. Godwin M.D. Pathology Laboratories and Breast Service, Memorial Center for Cancer and Allied Diseases, New York, New York Fellow, Pathology, American Cancer Society, Inc.Search for more papers by this authorGeorge C. Escher M.D., George C. Escher M.D. Pathology Laboratories and Breast Service, Memorial Center for Cancer and Allied Diseases, New York, New York Senior Damon Runyon Fellow and Assistant, Sloan-Kettering Institute, New York, New York.Search for more papers by this author John T. Godwin M.D., John T. Godwin M.D. Pathology Laboratories and Breast Service, Memorial Center for Cancer and Allied Diseases, New York, New York Fellow, Pathology, American Cancer Society, Inc.Search for more papers by this authorGeorge C. Escher M.D., George C. Escher M.D. Pathology Laboratories and Breast Service, Memorial Center for Cancer and Allied Diseases, New York, New York Senior Damon Runyon Fellow and Assistant, Sloan-Kettering Institute, New York, New York.Search for more papers by this author First published: January 1951 https://doi.org/10.1002/1097-0142(195101)4:1<136::AID-CNCR2820040114>3.0.CO;2-2Citations: 8 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Adair, F. E.: Surgical problems involved in breast cancer. Ann. Roy. Coll. Surgeons, England 4: 360– 380, 1949. 2 Adair, F. E. and Herrmann, J. B.: The use of testosterone propionate in the treatment of advanced carcinoma of the breast. Ann. Surg. 123: 1023– 1035, 1946. 3 Adair, F. E.: Mellors, R. C.: Farrow, J. H.; Woodard, H. Q.: Escher, G. C., and Urban, J. A.: The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of one hundred and five female patients. 7.A.M.: 140: 1193– 1200, 1949. 4 Frantz, V. K.: The prognostic significance of intracellular mucicarminophilic material in carcinoma of the female breast. Am. J. Cancer 33: 167– 181, 1938. 5 Hermann, J. B.; Adair, F. E., and Woodard, H. Q.: Effect of estrogenic hormone on advanced carcinoma of the female breast. Arch. Surg. 54: 1– 9, 1947. 6 Koller, P. C.: Addendum—cytology of serial biopsies from a case of carcinoma of the breast treated with stilboestrol. Brit. M. J. 2: 398, 1944. 7 Schenken, J. R.; Burns, E. L.. and Kahle, P. J.: The effect of diethylstilbestrol and diethylstilbestrol dipropionate on carcinoma of the prostate gland; cytologic changes following treatment. J. Urol. 48: 99– 112. 1942. 8 Taylor, S. G., III; Slaughter, D. P., Smejkal, W.; Fowler, E. F., and Prston, F. W.: The effect of sex hormones on advanced carcinoma of the breast. Cancer 1: 604– 617, 1948. 9 Watson, J. R., and Fetterman, G. H.: Testosterone propionate in the treatment of advanced carcinoma of the breast. Surg., Gynec. & Obst. 88: 702– 710, 1949. Citing Literature Volume4, Issue1January 1951Pages 136-140 ReferencesRelatedInformation